ArticleBlood advances2021

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation.

Juan Lázaro-Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.